11/14/2024
8:00 PM | Amicus Therapeutics (Subject)
Redmile Group, LLC (Filed by)
| Form SC 13G/A | |
11/14/2024
10:37 AM | Amicus Therapeutics (Subject)
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (Filed by)
| Form SC 13G | |
11/14/2024
8:31 AM | Amicus Therapeutics (Subject)
Avoro Capital Advisors LLC (Filed by)
| Form SC 13G/A | |
11/08/2024
9:52 AM | Amicus Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
11/07/2024
4:49 PM | Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2024
4:03 PM | Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2024
6:01 AM | Amicus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
11/04/2024
5:23 PM | Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2024
3:49 PM | Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/17/2024
6:00 AM | Amicus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/07/2024
12:24 PM | Amicus Therapeutics (Subject)
JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
| Form SC 13G/A | |
10/04/2024
3:05 PM | Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
3:35 PM | Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/03/2024
3:19 PM | Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/23/2024
4:10 PM | Amicus Therapeutics (Issuer)
Harford Simon N.R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
6:01 AM | Amicus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/05/2024
7:10 PM | Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/09/2024
4:01 PM | Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
3:22 PM | Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
6:54 PM | Amicus Therapeutics (Issuer)
WHITMAN BURKE W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
6:44 PM | Amicus Therapeutics (Issuer)
RAAB MICHAEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
6:46 PM | Amicus Therapeutics (Issuer)
SBLENDORIO GLENN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
6:47 PM | Amicus Therapeutics (Issuer)
Kelly Michael Aaron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
6:49 PM | Amicus Therapeutics (Issuer)
Bleil Lynn Dorsey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
6:52 PM | Amicus Therapeutics (Issuer)
ROBERTS EIRY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
6:53 PM | Amicus Therapeutics (Issuer)
WHEELER CRAIG A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
6:41 PM | Amicus Therapeutics (Issuer)
MCGLYNN MARGARET G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:38 PM | Amicus Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/05/2024
3:35 PM | Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
6:00 AM | Amicus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/24/2024
3:31 PM | Amicus Therapeutics (Filer)
| Form DEF 14A | |
04/24/2024
3:32 PM | Amicus Therapeutics (Filer)
| Form DEFA14A | |
04/16/2024
4:42 PM | Amicus Therapeutics (Issuer)
Prout Samantha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/15/2024
3:27 PM | Amicus Therapeutics (Subject)
Crowley John F (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/03/2024
5:14 PM | Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
4:52 PM | Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
6:12 PM | Amicus Therapeutics (Issuer)
Castelli Jeff (Reporting)
| Form 4/A | |
03/15/2024
6:13 PM | Amicus Therapeutics (Issuer)
Clark David Michael (Reporting)
| Form 4/A | |
03/15/2024
6:14 PM | Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
| Form 4/A | |
03/15/2024
6:15 PM | Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
| Form 4/A | |
03/15/2024
6:10 PM | Amicus Therapeutics (Issuer)
Rosenberg Ellen (Reporting)
| Form 4/A | |
2025 AI Stock Picks: 2 Hidden Gems Under $10/Share (Ad) The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget!
We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months. 👉[Click here to get your FREE report delivered instantly!] |
03/11/2024
4:36 PM | Amicus Therapeutics (Issuer)
SBLENDORIO GLENN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
4:21 PM | Amicus Therapeutics (Issuer)
MCGLYNN MARGARET G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
4:22 PM | Amicus Therapeutics (Issuer)
RAAB MICHAEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
4:35 PM | Amicus Therapeutics (Subject)
MCGLYNN MARGARET G (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024
3:39 PM | Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024
3:33 PM | Amicus Therapeutics (Subject)
Crowley John F (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2024
6:02 AM | Amicus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/20/2024
4:21 PM | Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
4:23 PM | Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
3:19 PM | Amicus Therapeutics (Subject)
Clark David Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/15/2024
3:19 PM | Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024
8:22 AM | Amicus Therapeutics (Subject)
Avoro Capital Advisors LLC (Filed by)
| Form SC 13G/A | |
02/08/2024
3:40 PM | Amicus Therapeutics (Issuer)
Rosenberg Ellen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
6:22 PM | Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
6:22 PM | Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/01/2024
3:44 PM | Amicus Therapeutics (Subject)
Crowley John F (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/01/2024
3:45 PM | Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/24/2024
4:20 PM | Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
3:18 PM | Amicus Therapeutics (Subject)
Crowley John F (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/18/2024
4:09 PM | Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2024
3:25 PM | Amicus Therapeutics (Subject)
Crowley John F (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/11/2024
5:33 PM | Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2024
5:34 PM | Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2024
5:34 PM | Amicus Therapeutics (Issuer)
Castelli Jeff (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2024
5:35 PM | Amicus Therapeutics (Issuer)
Clark David Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2024
5:35 PM | Amicus Therapeutics (Issuer)
Rosenberg Ellen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2024
3:06 PM | Amicus Therapeutics (Subject)
Crowley John F (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/09/2024
5:07 PM | Amicus Therapeutics (Issuer)
Prout Samantha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
5:08 PM | Amicus Therapeutics (Issuer)
Clark David Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
3:27 PM | Amicus Therapeutics (Subject)
Clark David Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/09/2024
3:27 PM | Amicus Therapeutics (Subject)
Prout Samantha (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024
8:09 AM | Amicus Therapeutics (Subject)
JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
| Form SC 13G | |
01/08/2024
6:01 AM | Amicus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2024
5:01 PM | Amicus Therapeutics (Issuer)
Prout Samantha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
5:01 PM | Amicus Therapeutics (Issuer)
Clark David Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
5:02 PM | Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
5:03 PM | Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
5:03 PM | Amicus Therapeutics (Issuer)
Rosenberg Ellen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
5:04 PM | Amicus Therapeutics (Issuer)
Castelli Jeff (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
5:24 PM | Amicus Therapeutics (Issuer)
Rosenberg Ellen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
5:26 PM | Amicus Therapeutics (Issuer)
Clark David Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
5:33 PM | Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
5:35 PM | Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
5:36 PM | Amicus Therapeutics (Issuer)
Castelli Jeff (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
5:17 PM | Amicus Therapeutics (Issuer)
Harford Simon N.R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
5:30 PM | Amicus Therapeutics (Issuer)
Prout Samantha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
3:32 PM | Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/02/2024
3:32 PM | Amicus Therapeutics (Subject)
Rosenberg Ellen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/29/2023
4:18 PM | Amicus Therapeutics (Issuer)
Amicus Therapeutics (Issuer)
Castelli Jeff (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
4:08 PM | Amicus Therapeutics (Issuer)
Rosenberg Ellen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
When it comes to NVDA… “acceleration cycles” are the key (Ad) Expert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options…
By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)...
And thanks to many months and late nights working out the kinks of the systems…
They have finally found a way to target these cycles on Nvidia over and over again. Use this link to see Nvidia Unchained right away! |
12/28/2023
4:09 PM | Amicus Therapeutics (Issuer)
Prout Samantha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
3:21 PM | Amicus Therapeutics (Subject)
Castelli Jeff (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/26/2023
3:25 PM | Amicus Therapeutics (Subject)
Rosenberg Ellen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/26/2023
3:25 PM | Amicus Therapeutics (Subject)
Prout Samantha (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/20/2023
3:41 PM | Amicus Therapeutics (Issuer)
Castelli Jeff (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
3:20 PM | Amicus Therapeutics (Subject)
Castelli Jeff (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/19/2023
4:54 PM | Amicus Therapeutics (Issuer)
Clark David Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
4:55 PM | Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
4:56 PM | Amicus Therapeutics (Issuer)
Rosenberg Ellen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
